'Cannabis painkiller drugs by summer'

13 April 2012

CANNABIS-based painkillers could be available on prescription as soon as this summer, said drugs developer GW Pharmaceuticals.

It will be a world first for the Wiltshire group, which grows cannabis plants at three secret locations. GW should get UK regulatory approval for its Sativex drug in the second quarter, slightly later than planned.

The drug will be used for multiple sclerosis and nerve damage pain.

Managing director Justin Gover said: 'This will be the first modern prescription medicine derived from cannabis, although it has been used as a tincture for 5,000 years.'

GW has a marketing deal with Bayer, which will pay it £14m when UK approval comes through. GW also hopes to get clearance to use Sativex in Europe and Canada, but admits that the US will take longer.

Annual losses reduced to £9.6m from £12.1m due to a £5m fee from Bayer.

Create a FREE account to continue reading

eros

Registration is a free and easy way to support our journalism.

Join our community where you can: comment on stories; sign up to newsletters; enter competitions and access content on our app.

Your email address

Must be at least 6 characters, include an upper and lower case character and a number

You must be at least 18 years old to create an account

* Required fields

Already have an account? SIGN IN

By clicking Create Account you confirm that your data has been entered correctly and you have read and agree to our Terms of use , Cookie policy and Privacy policy .

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged in